◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › C › CLPT

Clearpoint Neuro Inc (CLPT) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL DEVICES · DATA UPDATED 2026-11-02

Clearpoint Neuro Inc (CLPT) operates in the MEDICAL DEVICES industry and is headquartered in Solana Beach, United States with about 172 employees. Its market capitalization is roughly $342 million. In the fiscal year ended 2025-12-31, CLPT reported $37M in revenue and ($26M) in net income.

ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States.

Interactive charts & full statements → Open the CLPT valuation workbench →

CLPT Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-09-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31
Total Revenue	$45M	$37M	$31M	$24M	$21M	$16M	$13M	$11M	$7M	$7M	$6M	$5M	$4M	$4M	$5M	$4M	$3M
Gross Profit	$28M	$23M	$19M	$14M	$14M	$11M	$9M	$7M	$5M	$4M	$3M	$3M	$2M	$3M	$5M	$3M	$3M
Gross Margin %	62.2%	61.4%	60.9%	56.8%	65.8%	68.2%	71.1%	64.9%	66.9%	60.7%	54.0%	56.7%	46.5%	63.8%	89.0%	82.8%	99.4%
Operating Income (EBIT)	($31M)	($24M)	($20M)	($22M)	($16M)	($13M)	($6M)	($5M)	($5M)	($6M)	($7M)	($9M)	($5M)	($7M)	($3M)	($6M)	($10M)
Operating Margin %	-68.9%	-65.4%	-62.9%	-93.7%	-79.5%	-82.0%	-48.5%	-41.0%	-71.4%	-85.9%	-130.2%	-195.3%	-147.6%	-190.2%	-61.9%	-155.1%	-356.4%
Net Income	($37M)	($26M)	($19M)	($22M)	($16M)	($14M)	($7M)	($6M)	($6M)	($7M)	($8M)	($8M)	($5M)	($7M)	($6M)	($8M)	($9M)
Net Margin %	-82.2%	-69.1%	-60.2%	-92.2%	-80.0%	-88.4%	-52.9%	-49.4%	-83.8%	-97.1%	-140.4%	-183.9%	-125.5%	-180.3%	-112.8%	-217.7%	-354.2%
EBITDA	—	($21M)	($17M)	($21M)	($16M)	($13M)	($5M)	($4M)	($5M)	($6M)	($7M)	($7M)	($3M)	($6M)	($3M)	($5M)	($8M)
Earnings Per Share (EPS)	$-1.21	$-0.90	$-0.70	$-0.90	$-0.68	$-0.69	$-0.43	$-0.42	$-0.56	$-0.93	$-2.93	$-4.48	$-5.00	$-4.95	$-5.65	$-20.73	$-23.76
Shares Outstanding (M)	—	28M	27M	25M	24M	21M	16M	13M	11M	8M	3M	2M	1M	1M	1M	0M	0M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CLPT Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$12M	$11M	$12M	$10M	$9M	$9M	$8M	$8M	$8M
Gross Profit	$7M	$7M	$8M	$6M	$6M	$6M	$5M	$5M	$5M
Gross Margin %	58.3%	63.6%	62.2%	61.5%	63.2%	60.3%	60.5%	61.3%	59.7%
Operating Income (EBIT)	($6M)	($10M)	($8M)	($7M)	($5M)	($6M)	($6M)	($6M)	($5M)
Operating Margin %	-50.0%	-94.2%	-69.9%	-67.7%	-59.5%	-61.6%	-72.6%	-72.1%	-63.7%
Net Income	($8M)	($11M)	($10M)	($8M)	($6M)	($6M)	($6M)	($5M)	($5M)
Net Margin %	-66.7%	-104.2%	-78.8%	-74.8%	-66.5%	-63.3%	-71.0%	-69.3%	-61.2%
EBITDA	—	($9M)	($7M)	($6M)	($5M)	($5M)	($6M)	($5M)	($4M)
Earnings Per Share (EPS)	$-0.24	$-0.38	$-0.32	$-0.27	$-0.21	$-0.21	$-0.22	$-0.20	$-0.18
Shares Outstanding (M)	—	30M	30M	28M	28M	28M	28M	27M	28M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CLPT Free Cash Flow History

Cash flow	TTM → 2026-09-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31
Cash from Operations (CFO)	($32M)	($24M)	($9M)	($14M)	($16M)	($13M)	($8M)	($3M)	($5M)	($6M)	($6M)	($9M)	($7M)	($8M)	($7M)	($6M)	($8M)
Capital Expenditures (CapEx)	$1M	$1M	$0M	$1M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M
Free Cash Flow (FCF)	($33M)	($24M)	($9M)	($14M)	($16M)	($13M)	($8M)	($3M)	($5M)	($6M)	($6M)	($9M)	($7M)	($8M)	($8M)	($6M)	($8M)
FCF Margin %	-73.3%	-66.1%	-29.4%	-60.3%	-79.9%	-78.9%	-64.6%	-26.8%	-63.8%	-81.6%	-103.0%	-189.7%	-202.5%	-202.3%	-149.5%	-164.1%	-291.0%
Dividends Paid	—	—	—	—	$0M	$0M	—	—	—	—	—	—	—	—	—	—	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CLPT Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	($5M)	($7M)	($8M)	($12M)	($3M)	($3M)	($6M)	($1M)	($1M)
Capital Expenditures (CapEx)	$0M	$0M	$1M	$0M	$0M	$0M	$0M	$0M	$0M
Free Cash Flow (FCF)	($5M)	($7M)	($9M)	($12M)	($3M)	($3M)	($6M)	($2M)	($1M)
FCF Margin %	-41.7%	-66.4%	-71.0%	-116.5%	-37.5%	-28.7%	-74.9%	-19.4%	-14.9%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CLPT Balance Sheet History

Balance sheet	2026-09-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31
Total Assets	$113M	$98M	$39M	$43M	$55M	$66M	$30M	$12M	$8M	$14M	$7M	$10M	$13M	$8M	$6M	$3M
Cash & Cash Equivalents	$46M	$46M	$20M	$23M	$28M	$54M	$20M	$6M	$3M	$9M	$3M	$5M	$9M	$4M	$2M	$0M
Total Liabilities	$86M	$70M	$14M	$21M	$19M	$17M	$27M	$7M	$6M	$8M	$8M	$12M	$13M	$15M	$11M	$25M
Total Debt (Short + Long-Term)	$74M	$50M	$1M	$10M	$10M	$10M	$22M	$2M	$3M	$5M	$6M	$8M	$0M	$4M	$1M	$4M
Total Shareholders' Equity	$27M	$28M	$25M	$21M	$37M	$49M	$2M	$5M	$2M	$6M	($1M)	($2M)	$0M	($7M)	($6M)	($22M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CLPT viewer.

Other Companies in MEDICAL DEVICES

SSII · SS Innovations International Inc. Common Stock — $467 million
BWAY · Brainsway Ltd — $449 million
NPCE · Neuropace Inc — $422 million
OFIX · Orthofix Medical Inc — $369 million
PHG · Koninklijke Philips NV ADR — $28 billion
GKOS · Glaukos Corp — $14 billion
SNN · Smith & Nephew SNATS Inc — $13 billion
PEN · Penumbra Inc — $13 billion

← CLPS All “C” companies CLRB →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.